Endocannabinoid Tone and Oxylipins in Rheumatoid Arthritis and Osteoarthritis-A Novel Target for the Treatment of Pain and Inflammation?
2025International journal of molecular sciences
Klawitter J, Clauw AD, Seifert JA, Klawitter J, Tompson B +4 more
Plain English
This study looked at the role of certain natural compounds, called endocannabinoids and oxylipins, in patients with rheumatoid arthritis (RA) and osteoarthritis (OA) compared to healthy individuals. Researchers found that RA and OA patients had lower levels of a specific endocannabinoid (2-arachidonoylglycerol) and certain omega-3 fatty acids, which are important for managing pain and inflammation. This difference suggests that these compounds could be targeted for new treatments or nutritional supplements to help manage pain and inflammation in these conditions.
Who this helps: This helps patients with rheumatoid arthritis and osteoarthritis.